OSE Immunotherapeutics SA
OSE · EURONEXT · EUR
€2.08
−0.08 −3.70%todayNot financial advice.
- Open
- 2.24
- Day range
- 2.07 - 2.24
- 52-week range
- 2.01 - 6.48
- Volume
- 95.31K
- Market cap
- 57.11M
- P/E ratio
- —
- EPS
- —
- Dividend yield
- 0.00%
- Beta
- 0.56
Performance
W
−2.53%
1M
−21.80%
3M
−34.14%
6M
−33.59%
YTD
−60.12%
Y
−65.62%
5Y
−78.99%
All
−80.92%
In the news
Oct 19
OSE Immunotherapeutics Phase 2 Trial Meets Main Goal in Lung Cancer Study
OSE Immunotherapeutics met its primary goal in a Phase 2 lung cancer study, showing improved one-year survival rates for its Tedopi combinations.
Company news
Embed on your site
Embed docsAdd a live price card or a chart to any page. Free, no sign-up; cards refresh every minute and link back here.
<iframe src="https://stocks.freetheai.org/embed/EURONEXT-OSE" width="340" height="170" style="border:0;max-width:100%" loading="lazy" title="OSE Immunotherapeutics SA (OSE) - FreeTheAI Stocks"></iframe>
<p style="font-size:12px"><a href="https://stocks.freetheai.org/symbols/EURONEXT-OSE">OSE stock price</a> by FreeTheAI Stocks</p>